Loomis, Sayles & Company
CBST

Loomis, Sayles & Company’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Loomis, Sayles & Company’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-190,202
Closed -$13.3M – 775
2014
Q2 		$13.3M Sell
190,202
-7,503
-4% -$510K 0.04% 460
2014
Q1 		$14.5M Sell
197,705
-63,016
-24% -$4.7M 0.04% 440
2013
Q4 		$18M Sell
260,721
-119,322
-31% -$7.72M 0.05% 392
2013
Q3 		$24.2M Sell
380,043
-1,301
-0.3% -$78.6K 0.08% 261
2013
Q2 		$18.4K Buy
+381,344
New +$18.7M 0.07% 324

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company's CBST Position: Q3 2014 in Review

Loomis, Sayles & Company sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2014, closing a stake of 190,202 shares — an estimated $13.3M sold.

Loomis, Sayles & Company first reported a position in CBST in Q2 2013 and held it in 5 quarters. The position peaked at $24.2M in Q3 2013. 254 funds tracked by Wall St. Rank hold CBST as of Q3 2014.

  • Loomis, Sayles & Company reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Loomis, Sayles & Company sold 190,202 CUBIST PHARMACEUTICALS INC shares in Q3 2014, an estimated $13.3M.
  • Loomis, Sayles & Company first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Loomis, Sayles & Company's CUBIST PHARMACEUTICALS INC position peaked at $24.2M in Q3 2013.
  • 254 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2014.

Based on Loomis, Sayles & Company's 13F filing for Q3 2014, filed 14 Nov 2014.